Early post-infection treatment of sars-cov-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation

HIGHLIGHTS

• who: Koen K. A. Van Rompay and colleagues from the California National Primate Research Center, University of California, Davis, California, United States of have published the research: Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation, in the Journal: (JOURNAL) of March/24,/2022
• what: To further explore the potential benefit of CCP, and also to further validate the nonhuman primate model of SARS-CoV-2 to explore such passive immunotherapeutic interventions, this study tested a pooled . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.